Posted by 
The American Medical Assn. changes its policy to promote clinical research and development of cannabis-based medicines and alternative delivery methods.
By John Hoeffel~L.A. Times
The American Medical Assn. on Tuesday urged the federal government to reconsider its classification of marijuana as a dangerous drug with no accepted medical use, a significant shift that puts the prestigious group behind calls for more research.
The nation’s largest physicians organization, with about 250,000 member doctors, the AMA has maintained since 1997 that marijuana should remain a Schedule I controlled substance, the most restrictive category, which also includes heroin and LSD.
In changing its policy, the group said its goal was to clear the way to conduct clinical research, develop cannabis-based medicines and devise alternative ways to deliver the drug.
“Despite more than 30 years of clinical research, only a small number of randomized, controlled trials have been conducted on smoked cannabis,” said Dr. Edward Langston, an AMA board member, noting that the limited number of studies was “insufficient to satisfy the current standards for a prescription drug product.”
Related posts:
- Illinois Passes Medical Marijuana Bill
- U.S. To Yield Marijuana Jurisdiction To States
- Massachusetts voters decriminalize marijuana
- Illinois Senate approves bill to legalize medical marijuana
- Oregon May Legalize Marijuana
- RI Senate approves marijuana stores
- UPDATE: Marijuana Megastore Plants Roots in Oakland, California
- Biovail Fined $25M For Bribing Doctors To Prescribe Drug
- Marijuana user dies after denied transplant
- Merck Wrote Drug Studies for Doctors
- Poll: 81% favor legalizing medical marijuana
- Calif. judge orders police to return man’s 60 pounds of pot
